Annogen BV


At Annogen we use our SuRE™ technology to identify and develop bespoke human regulatory DNA elements to be used for controlled (therapeutic) gene expression for gene & cell therapy. The SuRE™ technology is also applied to identify regulatory elements from the cell line specific genome for recombinant protein production. In addition, we offer the AIM™ service to identify favorable gene insertions and their expression levels for more than 100,000 integrations in parallel. These approaches typically enable big improvements in any biomedical strategy involving the (over-) expression of genes. For more information, please visit

Get Involved with the Advanced Therapies Congress


To sponsor or exhibit

Ashlea Foster
+44 208 164 3032



To speak

Ila Dickinson
+44 207 092 1150